Drugs News and Research

RSS

Preliminary results of MSF malaria prevention program suggest malaria drugs prevent disease in healthy children

A large-scale malaria prevention program through which medical aid group Medecins Sans Frontieres (MSF) gave intermittent doses of anti-malaria drugs to 175,000 children in Mali and Chad suggests that "widely distributing anti-malaria drugs to healthy children in African countries can significantly reduce the number of new cases of the disease," VOA News reports.

26 Sep 2012

Orexin-A hormone also affects emergence after anesthesia

A neuropeptide hormone called orexin-A—which plays an important role in regulating the normal sleep-wake cycle—also affects emergence (waking up) after anesthesia, reports an experimental study in the October issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

26 Sep 2012

UCSD evaluates safety and tolerability of dexanabinol in Phase I brain cancer study

Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.

26 Sep 2012

State roundup: Anthem dumps Cedars-Sinai, UCLA docs

Two of the most prestigious names in Southern California health care -- Cedars-Sinai and UCLA -- are getting shut out of a major insurance plan for being too expensive. In a bold cost-cutting move, Anthem Blue Cross has eliminated doctors affiliated with the hospitals from a health plan offered to about 60,000 employees and dependents at the cash-strapped city of Los Angeles.

25 Sep 2012

New KSU molecule may deliver drugs inside the body to treat diseases

Kansas State University researchers have discovered a molecule that may be capable of delivering drugs inside the body to treat diseases.

25 Sep 2012

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

There are many different chronic respiratory diseases. Verona Pharma is mainly focused on two diseases: asthma and COPD. Asthma is a very common disease and unfortunately it has been increasing in prevalence in developed countries. This is the same with COPD; however, there may be different reasons for this.

25 Sep 2012

Small fragments of keratin protein in the eye play a key role in warding off pathogens

When it comes to germ-busting power, the eyes have it, according to a discovery by University of California, Berkeley, researchers that could lead to new, inexpensive antimicrobial drugs.

25 Sep 2012

New clinical trial to evaluate DEX-M74 against hereditary inclusion body myopathy

Researchers have launched a clinical trial to evaluate the drug candidate DEX-M74 as a treatment for a rare degenerative muscle disease, hereditary inclusion body myopathy (HIBM). National Institutes of Health scientists from the National Center for Advancing Translational Sciences (NCATS) and the National Human Genome Research Institute (NHGRI) will conduct the clinical trial at the NIH Clinical Center.

25 Sep 2012

Wiley announces publication of 6-volume Encyclopedia of Drug Metabolism and Interactions

Wiley is pleased to announce publication of the state-of-the-art, 6-volume Encyclopedia of Drug Metabolism and Interactions.

25 Sep 2012

UCLA/Pitt scientists uncover P. acnes virus with potential to kill zits

Watch out, acne. Doctors soon may have a new weapon against zits: a harmless virus living on our skin that naturally seeks out and kills the bacteria that cause pimples.

25 Sep 2012

FDA forms new internal task force to support development of new antibacterial drugs

The U.S. Food and Drug Administration today announced the formation of an internal task force that will support the development of new antibacterial drugs, a critical public health care goal and a priority for the agency.

25 Sep 2012

FIOCRUZ, DNDi and Brazil collaborate on R&D for neglected diseases

At the opening ceremony of the XVIII International Congress for Tropical Medicines and Malaria (ICTMM) and the XLVIII Congress of the Brazilian Society of Tropical Medicine in Rio de Janeiro, the Ministry of Health of Brazil signed a Cooperation and Technical Assistance Agreement with the Oswaldo Cruz Foundation (FIOCRUZ) and the Drugs for Neglected Diseases initiative (DNDi) Latin America, uniting the three actors into a strategic partnership to collaborate on research and development (R&D) for new therapies and diagnostics for neglected diseases.

25 Sep 2012

Anti-cancer EGFR inhibitors effective in reversing memory loss in animal models of Alzheimer's

A team of neuroscientists and chemists from the U.S. and China today publish research suggesting that a class of currently used anti-cancer drugs as well as several previously untested synthetic compounds show effectiveness in reversing memory loss in two animal models of Alzheimer's disease.

25 Sep 2012

New nanotechnology detects micrometastases in mouse models of breast cancer

Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths. New nanotechnology developed at Case Western Reserve University detects these metastases in mouse models of breast cancer far earlier than current methods, a step toward earlier, life-saving diagnosis and treatment.

25 Sep 2012

PPI use linked with risk for infection in decompensated cirrhosis

Proton-pump inhibitors are associated with an increased risk for serious infections in patients with decompensated cirrhosis, research shows.

24 Sep 2012

BG-12 effective for relapsing–remitting multiple sclerosis

Results of the CONFIRM and DEFINE studies suggest that dimethyl fumarate should be considered as an oral treatment for patients with relapsing–remitting multiple sclerosis.

24 Sep 2012

Fate of health law tied to GOP White House, Senate wins

Politico reports that Republicans may not get another chance to repeal "Obamacare" if they're unsuccessful at wresting control of the Senate and the executive branch this year. Other news outlets report on specific House and Senate races.

24 Sep 2012

ESMO Designated Center of Integrated Oncology and Palliative Care accreditation for 16 new centers

The European Society for Medical Oncology has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centers. The centers will receive the acknowledgment at the ESMO 2012 Congress, in Vienna, Austria, 28 September - 2 October.

24 Sep 2012

Conceptually novel mechanism for biological regulation of cell suicide

Death plays a big role in keeping things alive. Consider the tightly orchestrated suicide of cells--a phenomenon essential to everything from shaping an embryo to keeping it free of cancer later in life. When cells refuse to die, and instead multiply uncontrollably, they become what we call tumors. An intricate circuitry of biochemical reactions inside cells coordinates their self-sacrifice. Tracing that circuitry is, naturally, an important part of cancer research.

24 Sep 2012

Study to examine SYMPLICITY renal denervation system for treatment-resistant hypertension

The University of Michigan Cardiovascular Center will participate in a national clinical trial to treat the most challenging form of high blood pressure.

24 Sep 2012

Drugs News and Research

Preliminary results of MSF malaria prevention program suggest malaria drugs prevent disease in healthy children

Orexin-A hormone also affects emergence after anesthesia

UCSD evaluates safety and tolerability of dexanabinol in Phase I brain cancer study

State roundup: Anthem dumps Cedars-Sinai, UCLA docs

New KSU molecule may deliver drugs inside the body to treat diseases

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

Small fragments of keratin protein in the eye play a key role in warding off pathogens

New clinical trial to evaluate DEX-M74 against hereditary inclusion body myopathy

Wiley announces publication of 6-volume Encyclopedia of Drug Metabolism and Interactions

UCLA/Pitt scientists uncover P. acnes virus with potential to kill zits

FDA forms new internal task force to support development of new antibacterial drugs

FIOCRUZ, DNDi and Brazil collaborate on R&D for neglected diseases

Anti-cancer EGFR inhibitors effective in reversing memory loss in animal models of Alzheimer's

New nanotechnology detects micrometastases in mouse models of breast cancer

PPI use linked with risk for infection in decompensated cirrhosis

BG-12 effective for relapsing–remitting multiple sclerosis

Fate of health law tied to GOP White House, Senate wins

ESMO Designated Center of Integrated Oncology and Palliative Care accreditation for 16 new centers

Conceptually novel mechanism for biological regulation of cell suicide

Study to examine SYMPLICITY renal denervation system for treatment-resistant hypertension

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News